496 related articles for article (PubMed ID: 25218681)
1. Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis.
Zhang C; Zhang W; Chen HM; Liu C; Wu J; Shi S; Liu ZH
Am J Kidney Dis; 2015 Feb; 65(2):223-32. PubMed ID: 25218681
[TBL] [Abstract][Full Text] [Related]
2. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
Ramezani A; Devaney JM; Cohen S; Wing MR; Scott R; Knoblach S; Singhal R; Howard L; Kopp JB; Raj DS
Eur J Clin Invest; 2015 Apr; 45(4):394-404. PubMed ID: 25682967
[TBL] [Abstract][Full Text] [Related]
3. Urinary miR-196a predicts disease progression in patients with chronic kidney disease.
Zhang C; Liang S; Cheng S; Li W; Wang X; Zheng C; Zeng C; Shi S; Xie L; Zen K; Liu Z
J Transl Med; 2018 Apr; 16(1):91. PubMed ID: 29636065
[TBL] [Abstract][Full Text] [Related]
4. Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis.
Xiao B; Wang LN; Li W; Gong L; Yu T; Zuo QF; Zhao HW; Zou QM
Cell Death Dis; 2018 May; 9(5):533. PubMed ID: 29748623
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis.
Zhang Q; Zeng C; Fu Y; Cheng Z; Zhang J; Liu Z
Nephrology (Carlton); 2012 May; 17(4):338-45. PubMed ID: 22295953
[TBL] [Abstract][Full Text] [Related]
7. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
[TBL] [Abstract][Full Text] [Related]
8. Effect of plasma fractions from patients with focal and segmental glomerulosclerosis on rat proteinuria.
Le Berre L; Godfrin Y; Lafond-Puyet L; Perretto S; Le Carrer D; Bouhours JF; Soulillou JP; Dantal J
Kidney Int; 2000 Dec; 58(6):2502-11. PubMed ID: 11115084
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS.
Zhang W; Zhang C; Chen H; Li L; Tu Y; Liu C; Shi S; Zen K; Liu Z
Clin J Am Soc Nephrol; 2014 Sep; 9(9):1545-52. PubMed ID: 25107948
[TBL] [Abstract][Full Text] [Related]
10. [Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis].
Segarra A; Jatem E; Quiles MT; Arbós MA; Ostos H; Valtierra N; Carnicer C; Salcedo MT
Nefrologia; 2014; 34(1):53-61. PubMed ID: 24463863
[TBL] [Abstract][Full Text] [Related]
11. Urinary Exosomal miR-193a Can Be a Potential Biomarker for the Diagnosis of Primary Focal Segmental Glomerulosclerosis in Children.
Huang Z; Zhang Y; Zhou J; Zhang Y
Biomed Res Int; 2017; 2017():7298160. PubMed ID: 28246603
[No Abstract] [Full Text] [Related]
12. Higher Urine Exosomal miR-193a Is Associated With a Higher Probability of Primary Focal Segmental Glomerulosclerosis and an Increased Risk of Poor Prognosis Among Children With Nephrotic Syndrome.
Wang L; Wang J; Wang Z; Zhou J; Zhang Y
Front Cell Dev Biol; 2021; 9():727370. PubMed ID: 34708038
[No Abstract] [Full Text] [Related]
13. Primary focal segmental glomerulosclerosis in nephrotic patients: common complications and risk factors.
Zhang Q; Zeng C; Cheng Z; Xie K; Zhang J; Liu Z
J Nephrol; 2012; 25(5):679-88. PubMed ID: 22009935
[TBL] [Abstract][Full Text] [Related]
14. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
Cheng P; Xie Q; Liu S; Liu X; Wang L; Hao CM
Rev Assoc Med Bras (1992); 2024; 70(4):e20230871. PubMed ID: 38716932
[TBL] [Abstract][Full Text] [Related]
15. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
McCarthy ET; Sharma M; Savin VJ
Clin J Am Soc Nephrol; 2010 Nov; 5(11):2115-21. PubMed ID: 20966123
[TBL] [Abstract][Full Text] [Related]
16. Depletion of clusterin in renal diseases causing nephrotic syndrome.
Ghiggeri GM; Bruschi M; Candiano G; Rastaldi MP; Scolari F; Passerini P; Musante L; Pertica N; Caridi G; Ferrario F; Perfumo F; Ponticelli C
Kidney Int; 2002 Dec; 62(6):2184-94. PubMed ID: 12427144
[TBL] [Abstract][Full Text] [Related]
17. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
Shah L; Hooper DK; Okamura D; Wallace D; Moodalbail D; Gluck C; Koziell A; Zaritsky JJ
Pediatr Nephrol; 2019 Nov; 34(11):2343-2350. PubMed ID: 31250206
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).
Canaud G; Dion D; Zuber J; Gubler MC; Sberro R; Thervet E; Snanoudj R; Charbit M; Salomon R; Martinez F; Legendre C; Noel LH; Niaudet P
Nephrol Dial Transplant; 2010 Apr; 25(4):1321-8. PubMed ID: 19773419
[TBL] [Abstract][Full Text] [Related]
19. Tip variant of focal segmental glomerulosclerosis: outcome and comparison to 'not otherwise specified' variant.
Arias LF; Franco-Alzate C; Rojas SL
Nephrol Dial Transplant; 2011 Jul; 26(7):2215-21. PubMed ID: 21068139
[TBL] [Abstract][Full Text] [Related]
20. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
